Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). uri icon

authors

  • Cohen, Jordana B
  • Bryan, Nick
  • Supiano, Mark A
  • Sonnen, Joshua A
  • Weintraub, William S
  • Scharfstein, Daniel
  • Williamson, Jeff
  • Nick Pajewski, PhD
  • Bress, Adam P
  • Zachary Marcum, PharmD, PhD
  • Zhang, Chong
  • Derington, Catherine G
  • Greene, Tom H
  • Ghazi, Lama
  • Herrick, Jennifer S
  • King, Jordan B
  • Cheung, Alfred K

publication date

  • January 1, 2022